Tchaikapharma Highquality Medicines AD (XBUL:THQM) EPS (Basic) : лв0.05 (TTM As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is Tchaikapharma Highquality Medicines AD EPS (Basic)?

Tchaikapharma Highquality Medicines AD's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was лв0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was лв0.05.

Tchaikapharma Highquality Medicines AD's EPS (Diluted) for the three months ended in Mar. 2025 was лв0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was лв0.05.

Tchaikapharma Highquality Medicines AD's EPS without NRI for the three months ended in Mar. 2025 was лв0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 0.05.

During the past 12 months, Tchaikapharma Highquality Medicines AD's average EPS without NRIGrowth Rate was 53.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 38.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 27.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 9 years, Tchaikapharma Highquality Medicines AD's highest 3-Year average EPS without NRI Growth Rate was 78.80% per year. The lowest was -61.40% per year. And the median was -17.85% per year.

Tchaikapharma Highquality Medicines AD EPS (Basic) Historical Data

The historical data trend for Tchaikapharma Highquality Medicines AD's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tchaikapharma Highquality Medicines AD EPS (Basic) Chart

Tchaikapharma Highquality Medicines AD Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

0.01

0.02

0.03

0.04

0.05

Tchaikapharma Highquality Medicines AD Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															0.02	0.01	0.02	-	0.02

Tchaikapharma Highquality Medicines AD EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Tchaikapharma Highquality Medicines AD's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(4.49	-	0)	/	91.800
	=	0.05

Tchaikapharma Highquality Medicines AD's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(2.165	-	0)	/	96.471
	=	0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was лв0.05

Tchaikapharma Highquality Medicines AD (XBUL:THQM) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Tchaikapharma Highquality Medicines AD EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Tchaikapharma Highquality Medicines AD's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Tchaikapharma Highquality Medicines AD Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tchaikapharma Highquality Medicines AD (XBUL:THQM) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 G. M. Dimitrov Boulevard, Sofia, BGR, 1172

Website

https://www.tchaikapharma.com

Tchaikapharma Highquality Medicines AD is engaged in the business of manufacturing and selling pharmaceuticals in Bulgaria. The company specializes in both generic and in-licensed manufacturing. The company has medicines for Anaesthetics, Nervous system, Oncology, Anti-Inflammatory and Anti-Rheumatic, Antibiotics, Digestive system, diabetes and metabolism, and Respiratory system. The company generates all of its revenue from the sale of medicines. Geographically, the company generates the majority of its revenue from Bulgaria.

Tchaikapharma Highquality Medicines AD Headlines

No Headlines